178 related articles for article (PubMed ID: 16885335)
21. A genetic progression model of oral cancer: current evidence and clinical implications.
Braakhuis BJ; Leemans CR; Brakenhoff RH
J Oral Pathol Med; 2004 Jul; 33(6):317-22. PubMed ID: 15200478
[TBL] [Abstract][Full Text] [Related]
22. Profiling clonality and progression in multiple premalignant and malignant oral lesions identifies a subgroup of cases with a distinct presentation of squamous cell carcinoma.
Partridge M; Pateromichelakis S; Phillips E; Emilion G; Langdon J
Clin Cancer Res; 2001 Jul; 7(7):1860-6. PubMed ID: 11448897
[TBL] [Abstract][Full Text] [Related]
23. Expression of p16(INK4A), p53, and Rb proteins are independent from the presence of human papillomavirus genes in oral squamous cell carcinoma.
Nemes JA; Deli L; Nemes Z; Márton IJ
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2006 Sep; 102(3):344-52. PubMed ID: 16920543
[TBL] [Abstract][Full Text] [Related]
24. The hamster model of sequential oral oncogenesis.
Vairaktaris E; Spyridonidou S; Papakosta V; Vylliotis A; Lazaris A; Perrea D; Yapijakis C; Patsouris E
Oral Oncol; 2008 Apr; 44(4):315-24. PubMed ID: 18061531
[TBL] [Abstract][Full Text] [Related]
25. Increased expression of CENP-H gene in human oral squamous cell carcinomas harboring high-proliferative activity.
Shigeishi H; Higashikawa K; Ono S; Mizuta K; Ninomiya Y; Yoneda S; Taki M; Kamata N
Oncol Rep; 2006 Nov; 16(5):1071-5. PubMed ID: 17016595
[TBL] [Abstract][Full Text] [Related]
26. High levels of telomere dysfunction bestow a selective disadvantage during the progression of human oral squamous cell carcinoma.
Gordon KE; Ireland H; Roberts M; Steeghs K; McCaul JA; MacDonald DG; Parkinson EK
Cancer Res; 2003 Jan; 63(2):458-67. PubMed ID: 12543803
[TBL] [Abstract][Full Text] [Related]
27. Longitudinal study of TP53 mutations in eight patients with potentially malignant oral mucosal disorders.
Ogmundsdóttir HM; Hilmarsdóttir H; Björnsson J; Holbrook WP
J Oral Pathol Med; 2009 Oct; 38(9):716-21. PubMed ID: 19473449
[TBL] [Abstract][Full Text] [Related]
28. Multiple oral squamous epithelial lesions: are they genetically related?
Jang SJ; Chiba I; Hirai A; Hong WK; Mao L
Oncogene; 2001 Apr; 20(18):2235-42. PubMed ID: 11402318
[TBL] [Abstract][Full Text] [Related]
29. The use of exfoliative cell samples to map clonal genetic alterations in the oral epithelium of high-risk patients.
Rosin MP; Epstein JB; Berean K; Durham S; Hay J; Cheng X; Zeng T; Huang Y; Zhang L
Cancer Res; 1997 Dec; 57(23):5258-60. PubMed ID: 9393745
[TBL] [Abstract][Full Text] [Related]
30. Gene expression profile of oral squamous cell carcinomas from Sri Lankan betel quid users.
Suhr ML; Dysvik B; Bruland O; Warnakulasuriya S; Amaratunga AN; Jonassen I; Vasstrand EN; Ibrahim SO
Oncol Rep; 2007 Nov; 18(5):1061-75. PubMed ID: 17914555
[TBL] [Abstract][Full Text] [Related]
31. Inappropriate retinoic acid receptor-beta expression in oral dysplasias: correlation with acquisition of the immortal phenotype.
McGregor F; Wagner E; Felix D; Soutar D; Parkinson K; Harrison PR
Cancer Res; 1997 Sep; 57(18):3886-9. PubMed ID: 9307265
[TBL] [Abstract][Full Text] [Related]
32. Novel integrative methods for gene discovery associated with head and neck squamous cell carcinoma development.
Smith IM; Mithani SK; Liu C; Chang SS; Begum S; Dhara M; Westra W; Sidranksy D; Califano JA
Arch Otolaryngol Head Neck Surg; 2009 May; 135(5):487-95. PubMed ID: 19451471
[TBL] [Abstract][Full Text] [Related]
33. Identification of a gene signature for rapid screening of oral squamous cell carcinoma.
Ziober AF; Patel KR; Alawi F; Gimotty P; Weber RS; Feldman MM; Chalian AA; Weinstein GS; Hunt J; Ziober BL
Clin Cancer Res; 2006 Oct; 12(20 Pt 1):5960-71. PubMed ID: 17062667
[TBL] [Abstract][Full Text] [Related]
34. Comparison of p16(INK4a) expression with p53 alterations in head and neck cancer by tissue microarray analysis.
Karsai S; Abel U; Roesch-Ely M; Affolter A; Hofele C; Joos S; Plinkert PK; Bosch FX
J Pathol; 2007 Feb; 211(3):314-22. PubMed ID: 17152048
[TBL] [Abstract][Full Text] [Related]
35. Collagen XVIII modulation is altered during progression of oral dysplasia and carcinoma.
Väänänen A; Ylipalosaari M; Parikka M; Kainulainen T; Rehn M; Heljasvaara R; Tjäderhane L; Salo T
J Oral Pathol Med; 2007 Jan; 36(1):35-42. PubMed ID: 17181740
[TBL] [Abstract][Full Text] [Related]
36. Fluorescence in situ hybridization for detecting genomic alterations of cyclin D1 and p16 in oral squamous cell carcinomas.
Uzawa N; Sonoda I; Myo K; Takahashi K; Miyamoto R; Amagasa T
Cancer; 2007 Nov; 110(10):2230-9. PubMed ID: 17893905
[TBL] [Abstract][Full Text] [Related]
37. Hyaluronan-mediated motility: a target in oral squamous cell carcinoma.
Yamano Y; Uzawa K; Shinozuka K; Fushimi K; Ishigami T; Nomura H; Ogawara K; Shiiba M; Yokoe H; Tanzawa H
Int J Oncol; 2008 May; 32(5):1001-9. PubMed ID: 18425326
[TBL] [Abstract][Full Text] [Related]
38. Methylation of p16 CpG island associated with malignant progression of oral epithelial dysplasia: a prospective cohort study.
Cao J; Zhou J; Gao Y; Gu L; Meng H; Liu H; Deng D
Clin Cancer Res; 2009 Aug; 15(16):5178-83. PubMed ID: 19671846
[TBL] [Abstract][Full Text] [Related]
39. HPV and p53 expression in dysplastic lesions and squamous carcinomas of the oral mucosa.
Simionescu C; Mărgăritescu C; Georgescu CV; Surpăţeanu M
Rom J Morphol Embryol; 2005; 46(2):155-9. PubMed ID: 16287003
[TBL] [Abstract][Full Text] [Related]
40. Overexpression of COX-2 gene in oral cancer is independent of stage of disease and degree of differentiation.
Pandey M; Prakash O; Santhi WS; Soumithran CS; Pillai RM
Int J Oral Maxillofac Surg; 2008 Apr; 37(4):379-83. PubMed ID: 18356024
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
